The Chicago Transit Authority (CTA) has opened its new Lawrence, Argyle, Berwyn and Bryn Mawr Red Line stations. The station replacements are part of the $2.1 billion Red and Purple Modernization (RPM ...

Kaduna State Governor, Uba Sani, on Tuesday commissioned newly constructed homes for victims of banditry under Phase 1 of the Qatar Sanabil Project-a partnership between the Kaduna State Government ...

Kaduna State Governor, Senator Uba Sani, on Monday commissioned newly built homes for victims of banditry under Phase 1 of the Qatar Sanabil Project — a partnership between the Kaduna State Government ...

The 2025 MLB All-Star Game is just a few short weeks away, with the baseball world set to converge on Truist Park in Atlanta for the annual exhibition of the game's best and brightest.

Verastem Oncology Announces First Patient Dosed with VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, in a U.S. Phase 1/2a Trial in KRAS G12D Advanced Solid Tumors Phase 1 dose-escalation study to ...

Nearly one year after opening its doors, the UHS Wilson Main Tower at UHS Wilson Medical Center has become a defining symbol of a new era in healthcare for the Greater Binghamton region.

Lilly’s oral GLP-1, orforglipron, showed compelling efficacy and a safety profile consistent with injectable GLP-1 medicines, in complete Phase 3 results published in The New England Journal of ...

Lilly’s once-weekly insulin efsitora alfa demonstrated A1C reduction and a safety profile consistent with daily insulin in multiple Phase 3 trials ...

The sCAR-T platform developed by Calibr-Skaggs is designed to enhance the precision and safety of CAR-T therapies, and has demonstrated promising preliminary results in a phase 1 clinical trial ...

Eli Lilly has shared phase 1 data on amylin analog eloralintide, impressing analysts with results that point to the potential for the drug candidate to form part of a market-leading Zepbound ...

Schrödinger announces encouraging initial clinical data from its ongoing Phase 1 dose-escalation study of SGR-1505.

Kymera Therapeutics reported positive results from its phase 1 healthy volunteer study using KT-621. Click here to find out why KYMR stock is a Strong Buy.